COMPLICATIONS AND MONITORING OF OKT3 THERAPY

被引：189

作者：

THISTLETHWAITE, JR

STUART, JK

MAYES, JT

GABER, AO

WOODLE, S

BUCKINGHAM, MR

STUART, FP

机构：

来源：

AMERICAN JOURNAL OF KIDNEY DISEASES | 1988年 / 11卷 / 02期

关键词：

D O I：

10.1016/S0272-6386(88)80192-6

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：112 / 119

页数：8

共 10 条

[1]

COSIMI AB, 1981, TRANSPLANT P, V13, P462

[2] OKT3 MONOCLONAL-ANTIBODY PLASMA-LEVELS DURING THERAPY AND THE SUBSEQUENT DEVELOPMENT OF HOST ANTIBODIES TO OKT3 [J].

GOLDSTEIN, G ;

FUCCELLO, AJ ;

NORMAN, DJ ;

SHIELD, CF ;

COLVIN, RB ;

COSIMI, AB .

TRANSPLANTATION, 1986, 42 (05) :507-511

[3]

GOLDSTEIN G, 1985, TRANSPLANT P, V17, P129

[4] MONOCLONAL-ANTIBODY THERAPY - ANTIIDIOTYPIC AND NON-ANTI-IDIOTYPIC ANTIBODIES TO OKT3 ARISING DESPITE INTENSE IMMUNOSUPPRESSION [J].

JAFFERS, GJ ;

FULLER, TC ;

COSIMI, AB ;

RUSSELL, PS ;

WINN, HJ ;

COLVIN, RB .

TRANSPLANTATION, 1986, 41 (05) :572-578

[5]

MAYES JT, IN PRESS TRANSPLANTA

[6] IMMUNOLOGICAL MONITORING DURING AND AFTER OKT3 THERAPY [J].

SHIELD, CF ;

NORMAN, DJ .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1988, 11 (02) :120-124

[7] USE OF A BRIEF STEROID TRIAL BEFORE INITIATING OKT3 THERAPY FOR RENAL-ALLOGRAFT REJECTION [J].

THISTLETHWAITE, JR ;

STUART, JK ;

MAYES, JT ;

GABER, AO ;

STUART, FP .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1988, 11 (02) :94-98

[8]

THISTLETHWAITE JR, 1987, TRANSPLANTATION, V43, P176

[9] EVOLVING USE OF OKT3 MONOCLONAL-ANTIBODY FOR TREATMENT OF RENAL-ALLOGRAFT REJECTION [J].

THISTLETHWAITE, JR ;

COSIMI, AB ;

DELMONICO, FL ;

RUBIN, RH ;

TALKOFFRUBIN, N ;

NELSON, PW ;

FANG, L ;

RUSSELL, PS .

TRANSPLANTATION, 1984, 38 (06) :695-700

[10]

1985, N ENGL J MED, V313, P337

← 1 →